Nasal spray offers new hope for dry eye sufferers
NCT ID NCT05514041
First seen May 06, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This study tested a nasal spray called OC-01 (varenicline) in 50 adults with dry eye disease. The goal was to see if it improves tear film quality and stability compared to a placebo spray. Participants used the spray and had their tears measured at a single visit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stephenson Eye Associates
Venice, Florida, 34285, United States
Conditions
Explore the condition pages connected to this study.